Axios @axios
Black leukemia patients ages 18-29 were likelier to die early or not go into full remission than their white peers with the same intensive treatment, a study finds. It suggests a one-size-fits-all approach that includes chemo may not be optimal for some. https://t.co/qqZBy2p7OW — PolitiTweet.org